ArticleJournal of current ophthalmology
Incidence, Prevalence, and Ocular Comorbidities of Primary Vitreoretinal Lymphoma in the TriNetX Global Collaborative Network.
Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To characterize the epidemiology of primary vitreoretinal lymphoma (PVRL), a rare malignancy of the central nervous system (CNS) that presents with vitritis and chorioretinal infiltrates and is closely associated with primary CNS lymphoma. Limited literature describes an incidence between 0.023 and 0.46/100,000 that has been increasing. The epidemiology of PVRL remains poorly characterized in large-scale datasets. We evaluated the baseline demographics, incidence, and prevalence of PVRL and ocular comorbidities using the TriNetX Global Collaborative Network database. Methods: A retrospective cohort study was conducted using TriNetX using the 10 Results: Among 152,281,229 patients in the TriNetX network, 175 were identified as probable PVRL cases. The 10-year cumulative prevalence was estimated at 0.076 per 100,000 persons. The mean age at diagnosis was 59.4 years (standard deviation: 15.6; range: 19-90), and 59.52% were Caucasian. Postdiagnosis comorbidities included glaucoma (15.0%), cystoid macular edema (13.6%), and low vision (13.2%). Conclusions: This study provides an updated, large population-based assessment of the 10-year cumulative prevalence of PVRL using a global electronic health record database. These findings contribute to the limited literature on PVRL prevalence and offer insights into disease burden across diverse international populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.